CompanyGraph
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- ScaleMarket cap is $1.42B, above the global median of $1.15B
- FinancialsAltman Z-Score 2.98: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.52BCNY1.42B · vs all stocks (USD)
Revenue (TTM)
277.82MCNY41.31M · vs all stocks (USD)
Profit Margin
-203.13%vs Biotechnology peers
Beta
0.6360xvs all stocks
52-Week Change
-22.38%vs all stocks
Market Capitalization
9.52BCNY1.42B · vs all stocks (USD)
Enterprise Value
8.53BCNY1.27B · vs all stocks (USD)
Forward P/E
-9.77xvs Biotechnology peers
Price to Sales (TTM)
35.35xvs Biotechnology peers
Price to Book (MRQ)
6.84xvs Biotechnology peers
Enterprise to Revenue
30.72xvs Biotechnology peers
Enterprise to EBITDA
-15.49xvs Biotechnology peers
Gross Margin
86.85%vs Biotechnology peers
Profit Margin
-203.13%vs Biotechnology peers
Operating Margin
-219.84%vs Biotechnology peers
Return on Assets (TTM)
-12.52%vs Biotechnology peers
Return on Equity (TTM)
-32.85%vs Biotechnology peers
Revenue (TTM)
277.82MCNY41.31M · vs all stocks (USD)
Revenue per Share (TTM)
0.7580CNYUpdated Aug 21, 2026Quarterly Revenue Growth
233.60%vs Biotechnology peers
Gross Profit (TTM)
255.83MCNY38.04M · vs all stocks (USD)
EBITDA (TTM)
-550.90MCNY-81.92M · vs all stocks (USD)
Net Income (TTM)
-564.33MCNY-83.92M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
281.93%vs Biotechnology peers
Operating Cash Flow (TTM)
-392.62MCNY-58.39M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-337.43MCNY-50.18M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Biotechnology peers
Revenue
230.73MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
16.09MCNYFY2025 · Dec 31, 2025Gross Profit
214.63MCNYFY2025 · Dec 31, 2025Operating Income
-545.56MCNY-81.13M · vs all stocks (USD)
Pre-tax Income
-535.65MCNYFY2025 · Dec 31, 2025Net Income
-535.65MCNYFY2025 · Dec 31, 2025EBIT
-504.24MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-436.92MCNYFY2025 · Dec 31, 2025Research & Development
472.83MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
150.63MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.94MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
35.87MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
31.41MCNYFY2025 · Dec 31, 2025EPS (Basic)
-1.46CNYFY2025 · Dec 31, 2025EPS (Diluted)
-1.46CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
366.88MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
366.88MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-535.65MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-538.10MCNYFY2025 · Dec 31, 2025Free Cash Flow
-623.42MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.54BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-535.65MCNYFY2025 · Dec 31, 2025Other Non-cash Items
36.50MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
6.06MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-45.01MCNYFY2025 · Dec 31, 2025Capital Expenditures
-85.32MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.80BCNYFY2025 · Dec 31, 2025Sale of Investments
2.54BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-340.70MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
892.25MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-660.92MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-30.51MCNYFY2025 · Dec 31, 2025Other Financing Charges
-19.93MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
180.88MCNYFY2025 · Dec 31, 2025Shares Outstanding
366.68MSharesUpdated Aug 21, 2026Float Shares
111.22MSharesUpdated Aug 21, 2026% Held by Insiders
70.36%vs all stocks
% Held by Institutions
5.71%vs all stocks
Total Cash (MRQ)
2.15BCNY319.83M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.87CNYUpdated Aug 21, 2026Total Debt (MRQ)
1.20BCNY177.84M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.8331xvs Biotechnology peers
Current Ratio (MRQ)
4.78xvs Biotechnology peers
Book Value per Share (MRQ)
3.91CNYUpdated Aug 21, 2026Total Assets
2.99BCNY445.14M · vs all stocks (USD)
Total Current Assets
2.44BCNYFY2025 · Dec 31, 2025Total Liabilities
1.41BCNYFY2025 · Dec 31, 2025Total Non-current Assets
550.03MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
935.84MCNYFY2025 · Dec 31, 2025Total Current Liabilities
472.72MCNYFY2025 · Dec 31, 2025Cash
1.54BCNYFY2025 · Dec 31, 2025Cash Equivalents
143.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.54BCNYFY2025 · Dec 31, 2025Other Short-term Investments
681.23MCNYFY2025 · Dec 31, 2025Accounts Receivable
21.08MCNYFY2025 · Dec 31, 2025Inventory
96.12MCNYFY2025 · Dec 31, 2025Accounts Payable
95.43MCNYFY2025 · Dec 31, 2025Short-term Debt
169.88MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.47MCNYFY2025 · Dec 31, 2025Long-term Debt
892.80MCNYFY2025 · Dec 31, 2025Common Stock (Book)
366.68MCNYFY2025 · Dec 31, 2025Retained Earnings
-2.95BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.58BCNY235.67M · vs all stocks (USD)
Treasury Stock
20.30MCNYFY2025 · Dec 31, 202552-Week Low
20.07CNYUpdated Aug 21, 202652-Week High
37.88CNYUpdated Aug 21, 202652-Week Change
-22.38%vs all stocks
Beta
0.6360xvs all stocks
50-Day MA
23.83CNYUpdated Aug 21, 2026200-Day MA
27.08CNYUpdated Aug 21, 2026Avg 10-Day Volume
5.20MSharesUpdated Aug 21, 2026Avg 30-Day Volume
4.60MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-1.54CNYUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.87Profit Margin: -2.03
Financial Health
Altman Z-Score 2.98: safe zoneNotable
Altman Z-Score: 2.98
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Scale
Market cap is $1.42B, above the global median of $1.15BNotable
Market cap (USD): 1,415,027,103.66Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai MicroPort EP MedTech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangxi Fushine Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Qingdao Haier Biomedical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Aurora Optoelectronics Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlow
Absci Corporation
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
KalVista Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
HBM Holdings Limited
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Shandong Xinhua Pharmaceutical Company Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Inspire Medical Systems, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Vcanbio Cell & Gene Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule